5 results match your criteria: "and Revista de Investigación Clínica - Clinical and Translational Investigation[Affiliation]"

REVISTA DE INVESTIGACIóN CLíNICA -CLINICAL AND TRANSLATIONAL INVESTIGATION-: EDITORS' CHOICES 6 YEARS LATER.

Rev Invest Clin

December 2021

Deputy Editor, RIC, and Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" (INER), Mexico City, Mexico.

In this article, a series of original manuscripts and reviews published between 2015 and 2021 in the Revista de Investigación Clínica -Clinical and Translational Investigation- chosen by the Editors are presented. The articles were selected according to what the editors considered are the most outstanding contributions based on originality, and the potential impact of the information provided on translational medicine, rather than on the number of readings and citations.

View Article and Find Full Text PDF

PREFACE.

Rev Invest Clin

December 2021

Director General, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

View Article and Find Full Text PDF

This symposium describes the main characteristics of six Mexican scientific journals indexed in Journal Citation Reports: Archives of Medical Research, Revista de Investigación Clínica-Clinical and Translational Investigation, Gaceta Médica de México, Salud Pública de México, Cirugía y Cirujanos and Salud Mental. Particular emphasis is given to their historical and organizational aspects, as well as to their main achievements recognized by the national and international scientific community. En este simposio se describen las principales características de seis revistas científicas mexicanas reconocidas por el.

View Article and Find Full Text PDF

Preface.

Rev Invest Clin

December 2017

Red de Apoyo a la Investigación, Universidad Nacional Autónoma de México-Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, and Editor-in-Chief, Revista de Investigación Clínica -Clinical and Translational Investigation-, Mexico.

Breast cancer (BC) is the most frequently diagnosed malignancy in young women and is the leading cause of cancer-related mortality in this age group. This issue represents a major public health problem in developing countries, where the incidence of BC is rapidly increasing and where young women represent a higher proportion of the total BC patient population compared to developed countries. In Latin America, BC among women aged 40 years or less accounts for up to 11% of new BC cases and 7% of all BC deaths.

View Article and Find Full Text PDF